Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can kids with eczema safely use sunscreen? new study says yes

NCT ID NCT07194408

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a broad-spectrum SPF50+ sunscreen on 22 children with mild-to-moderate atopic dermatitis (eczema). The goal was to see how well the children's skin tolerated the sunscreen when applied at least twice daily. Doctors rated tolerance as excellent, very good, good, moderate, or bad, and parents also gave feedback. The study is already completed, and results will show whether this sunscreen is a good option for kids with sensitive, eczema-prone skin.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sunscreen (SPF50+, broad-spectrum)
What this could lead to
If successful, this could show that a specific sunscreen is safe and well-tolerated for children with eczema, helping them protect their skin without irritation.
What could go wrong
This is a small, completed study with only 22 children, so results may not apply to all kids with eczema. It only looked at tolerance, not whether the sunscreen prevents flares or sun damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

22 people

The number who actually took part.

Started

Dec 2023

Finished

Feb 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Subjects will be recruited from the investigation centre's panel. They will be selected on the basis of inclusion and non-inclusion criteria specific to the study and on their ability to comply with the constraints required by the protocol. They will be definitely included in the study after a specific interview and a clinical examination.

Ages

3 to 11 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Criteria related to the population: * phototype: I to IV; * face and body skin type: all skin types; * subjects must be registered with health social security or health social insurance (if required by national regulations); * subjects' parent(s)/ legal representatives having signed their written Informed Consent form for their participation in the study and a photograph authorization; * subjects' parent(s)/ legal representatives certifying the truth of the personal information declared to the Investigator; * Health Status: Considered a "healthy subject" by the Investigators (excluding SCORAD considerations). Criteria Related to Atopic Dermatitis: \- Subject must present atopic dermatitis according to the U.K Working Party's Diagnostic Criteria for Atopic Dermatitis, with mild atopic dermatitis indicated by a SCORAD score of 15 to 25 (inclusive), determined by a dermatologist and a pediatrician together. Non-Inclusion Criteria: Criteria Related to Population: * Subjects who have participated in another clinical trial within the week before the inclusion visit, or for a longer period if deemed necessary by the Investigator. * Subjects currently participating or planning to participate in another clinical trial during the study, either in the same or a different investigation center. Criteria Related to Subject's Health: * Subjects experiencing a flare of atopic dermatitis. * Subjects with dermatological conditions that may interfere with study data or are considered hazardous by the Investigator (e.g., pityriasis versicolor, severe pigmentation disorders such as vitiligo, melasma, multiple lentigines, numerous or large congenital nevi). * Subjects with a personal medical history that may interfere with study data or is incompatible with study requirements (except if required by the Sponsor, e.g., atopic dermatitis).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Atopic dermatitis (AD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Insight Research

    Quatre Bornes, Mauritius, 72218, Mauritius

More trials for these conditions

Other studies related to the condition(s) this trial covers.